Phase II study of amrubicin (SM-5887), a novel 9-amino-anthracycline, in previously untreated patients with extensive stage small-cell lung cancer (ES-SCLC) : a West Japan Lung Cancer Group trial

• YANA T.

収録刊行物

• American Society of Clinical Oncology 34th Annual Meeting

  American Society of Clinical Oncology 34th Annual Meeting 1734 1998

詳細情報

• CRID: 1572543024569509120
• NII論文ID: 10008087739
• データソース種別:
  • CiNii Articles